Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Atopic Hypersensitivity”

1,672 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,672 results

Testing effectiveness (Phase 2)Study completedNCT04836858
What this trial is testing

Assess the Efficacy and Safety of CMK389 in Patients With Moderate to Severe Atopic Dermatitis.

Who this might be right for
Atopic Dermatitis
Novartis Pharmaceuticals 71
Large-scale testing (Phase 3)Study completedNCT03661138
What this trial is testing

Evaluate Safety of Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
AbbVie 272
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07782333
What this trial is testing

A Study Evaluating TRIV-573 in Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Triveni Bio 90
Post-approval studies (Phase 4)Study completedNCT00119158
What this trial is testing

Combination Therapy for Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Children's Hospital of Philadelphia 90
Not applicableLooking for participantsNCT03936335
What this trial is testing

An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis (AD)

Who this might be right for
Adverse Pregnancy OutcomesAtopic Dermatitis
Regeneron Pharmaceuticals 3,930
Not applicableLooking for participantsNCT04462978
What this trial is testing

Non-Immunoglobulin E-mediated Food Allergies in Children

Who this might be right for
Non IgE Mediated Food AllergyFood Protein-Induced EnteropathyFood Protein-Induced Proctocolitis+2 more
Federico II University 150
Testing effectiveness (Phase 2)Study completedNCT04194814
What this trial is testing

Skin bioMARkers for Atopic Eczema Therapy Evaluation

Who this might be right for
Atopic Eczema/Dermatitis (Non-Specific)
Sheffield Teaching Hospitals NHS Foundation Trust 37
Not applicableStudy completedNCT03981926
What this trial is testing

Team-Based Connected Health (TCH) to Improve Clinical Outcomes and Access in Atopic Dermatitis

Who this might be right for
Atopic Dermatitis EczemaAtopic DermatitisEczema
University of Southern California 300
Not applicableEnded earlyNCT04462055
What this trial is testing

Effectiveness of Dupilumab in Food Allergic Patients With Moderate to Severe Atopic Dermatitis

Who this might be right for
Food Allergy
UMC Utrecht 3
Early research (Phase 1)Study completedNCT05114889
What this trial is testing

Safety and Tolerability of BSI-045B in Healthy Adult Subjects and Patients With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Biosion, Inc. 54
Not applicableUnknownNCT01307150
What this trial is testing

Climatotherapy At The Dead Sea For Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Hadassah Medical Organization 50
Testing effectiveness (Phase 2)Ended earlyNCT04990440
What this trial is testing

Bermekimab for the Treatment of Adult Participants With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic
Janssen Research & Development, LLC 6
Post-approval studies (Phase 4)Active Not RecruitingNCT05983068
What this trial is testing

Long-term Effect of Dupilumab on Skin Barrier Function in Pediatric Participants With Atopic Dermatitis

Who this might be right for
Dermatitis Atopic
Sanofi 48
Large-scale testing (Phase 3)Looking for participantsNCT06775860
What this trial is testing

ICP-332 in Subjects With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Beijing InnoCare Pharma Tech Co., Ltd. 552
Post-approval studies (Phase 4)Study completedNCT03406117
What this trial is testing

Determine the Safety and Sensitizing Potential of HAT1 Topical Products Using Skin Sensitivity Patch Tests

Who this might be right for
HealthyAtopic DermatitisPsoriasis
Haus Bioceuticals 182
Large-scale testing (Phase 3)Study completedNCT00560378
What this trial is testing

Long-term Safety of Protopic in Atopic Eczema

Who this might be right for
Dermatitis, AtopicEczema, Atopic
Astellas Pharma Inc 789
Not applicableActive Not RecruitingNCT03992417
What this trial is testing

Observational Study of Patients Receiving Dupixent® for Atopic Dermatitis (AD)

Who this might be right for
Dermatitis Atopic
Sanofi 955
Not applicableLooking for participantsNCT05420935
What this trial is testing

Repertoire and Properties of Anti-drug Antibodies Involved in Immediate Hypersensitivity in the Operating Room

Who this might be right for
Hypersensitivity, ImmediatePeri-operative InjuryAntibiotic Allergy+1 more
Assistance Publique - Hôpitaux de Paris 40
Post-approval studies (Phase 4)Study completedNCT03832010
What this trial is testing

Steroid-reducing Effects of Crisaborole

Who this might be right for
Atopic DermatitisEczema
Johns Hopkins University 24
Not applicableStudy completedNCT01326520
What this trial is testing

Effect of Dietary Phospholipids on Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic
University of Jena 39
Next Page